NRSN icon

NeuroSense Therapeutics

8 hedge funds and large institutions have $304K invested in NeuroSense Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$129K +$129K +71,100 New
MIH
2
Meitav Investment House
Israel
$91K -$81.9K -45,000 -47%
WP
3
Woodline Partners
California
$35.6K +$35.6K +19,581 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$21.8K
UBS Group
5
UBS Group
Switzerland
$21.7K +$11.7K +6,432 +117%
Morgan Stanley
6
Morgan Stanley
New York
$2.73K -$2.73K -1,500 -50%
Carson Wealth (CWM LLC)
7
Carson Wealth (CWM LLC)
Nebraska
$2K
Qube Research & Technologies (QRT)
8
Qube Research & Technologies (QRT)
United Kingdom
$98
HF
9
HRT Financial
New York
-$10K -13,998 Closed
SRL
10
Scientech Research LLC
New Jersey
-$10.1K -12,584 Closed